Immune thrombocytopenia in two infant cases managed with eltrombopag

Pediatr Blood Cancer. 2021 Sep;68(9):e29120. doi: 10.1002/pbc.29120. Epub 2021 May 28.

Authors

Giulia Ceglie^{1

2}, Giulia Nocentini^{3

4}, Francesca De Gennaro^{3

4}, Vitangelo Clemente^{3

4}, Margherita Di Mauro^{3

4}, Giuseppe Palumbo^{1

4}

Affiliations

¹ Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
² Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
³ University Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
⁴ University of Rome Tor Vergata, Rome, Italy.

PMID: 34047051
DOI: 10.1002/pbc.29120

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Benzoates / therapeutic use*
Humans
Hydrazines / therapeutic use*
Infant
Purpura, Thrombocytopenic, Idiopathic* / drug therapy
Pyrazoles / therapeutic use*
Thrombocytopenia* / drug therapy
Treatment Outcome

Substances

Benzoates
Hydrazines
Pyrazoles
eltrombopag